IKS Health Q1 FY27: Growth holds, TruBridge integration takes center stage
Frequently Asked Questions
Revenue from operations was INR 8,936 million, EBITDA was INR 2,949 million (33.0% margin), and PAT was INR 1,937 million (21.7% margin).
Revenue grew 20.7% year on year in INR terms and 12% year on year in USD terms, as presented in the investor deck.
Operating cash flow was INR 1,742 million and free cash flow was INR 1,999 million; the company noted these are adjusted for an upfront guarantee payment made to a customer.
The company disclosed completion of acquisition of 100% of TruBridge, Inc. for total consideration of USD 557 million in the July 9, 2026 exchange filing.
Management reiterated a True North objective to reach at least INR 30,000 million EBITDA by FY30, with no significant equity dilution beyond ESOPs and net debt returning to pre-TruBridge levels.
Top 10 customers contributed 53.8% of revenue and top 5 contributed 42.1% in Q1 FY27, per the investor presentation.
The presentation listed IKS Scribble, MyCareHub, IKS AssurRx, and IKS Stacks among its automation and platform offerings across patient journey phases.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker